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tRNA restriction by anticodon nucleases underlies
cellular stress responses and self-nonself discrimi-
nation in a wide range of taxa. Anticodon breakage
inhibits protein synthesis, which, in turn, results
in growth arrest or cell death. The eukaryal ribo-
toxin PaT secreted by Pichia acaciae inhibits
growth of Saccharomyces cerevisiae via cleavage
of tRNAGln(UUG). We find that recombinant PaT in-
cises a synthetic tRNAGln(UUG) stem-loop RNA by
transesterification at a single site 30 of the wobble uri-
dine, yielding 20,30-cyclic phosphate and 50-OH ends.
Incision is suppressed by replacement of the wobble
nucleobase with adenine or guanine. The crystal
structure of PaT reveals a distinctive fold and active
site, essential components of which are demon-
strated by mutagenesis. Pichia acaciae evades self-
toxicity via a distinctive intracellular immunity pro-
tein, ImmPaT, which binds PaT and blocks nuclease
activity. Our results highlight the evolutionary diver-
sity of tRNA restriction and immunity systems.
INTRODUCTION
The yeast Pichia acaciae secretes a tRNA anticodon nuclease
toxin encoded by a resident cytoplasmic linear DNA ‘‘killer’’
plasmid (Satwika et al., 2012). The secreted form of the ribotoxin
is a complex of PaOrf1 and PaOrf2 subunits that arrests growth
of the nonself yeast Saccharomyces cerevisiae (Figure 1A). The
chitin-binding PaOrf1 subunit interacts with the target cell sur-
face to effect the delivery of the PaOrf2 subunit—the Pichia
acaciae toxin, PaT—into the cytoplasm of the target cell. PaT
elicits toxicity in vivo via cleavage of the anticodon loop of
tRNAGln(UUG) (Figure 1B), thereby depleting the functional pool
of this isoacceptor (Klassen et al., 2008). To prevent self-killing,
either by autocrine uptake of secreted toxin or by residual free
cytoplasmic PaT, the killer plasmid encodes an immunity factor
ImmPaT (the PaOrf4 protein) that protects P. acaciae via an
unknown mechanism (Paluszynski et al., 2007).
The yeast Kluyveromyces lactis has an analogous system of
self-nonself discrimination via the secreted toxin zymocin, theg-toxin subunit of which is an anticodon nuclease that targets
tRNAGlu(UUC) (Lu et al., 2005). In addition to their primary targets,
PaT and g-toxin can also cleave, albeit to a lesser extent, the two
other yeast tRNAs that have an mcm5s2U wobble base: tRNAGlu
and tRNALys for PaT; tRNAGln and tRNALys for g-toxin (Lu et al.,
2005; Klassen et al., 2008). Whereas g-toxin is strictly dependent
on thewobblemcm5modification for its ribotoxicity, PaT is not. It
is noteworthy that, despite their tRNA substrate overlap, PaT has
no apparent primary structure similarity to K. lactis g-toxin. Nor
does the PaT primary structure resemble any of the exemplary
bacterial tRNA anticodon nucleases: PrrC (Blanga-Kanfi et al.,
2006), colicin E5 (Ogawa et al., 1999), colicin D (Tomita et al.,
2000), or VapC (Winther and Gerdes, 2011). Indeed, PaT
has no similarity to any known nucleases or phosphotrans-
ferases. Its sole retrievable homolog is a plasmid-encoded toxin
of unknown target specificity from the yeast Debaryomyces
robertsiae (Klassen et al., 2004).
The fungal ribotoxins are a fertile area for exploring the mech-
anisms, structures, and evolution of eukaryal tRNA restriction
enzymes, which are of heightened interest in light of recent dis-
coveries of tRNA restriction as a general eukaryal response
to cellular stress (Thompson and Parker, 2009; Saikia et al.,
2012). g-Toxin has been studied genetically and biochemically.
It has been mutagenized extensively, and its cleavage mecha-
nism and specificity have been defined using native tRNAs and
synthetic RNA substrates that mimic the anticodon stem-loop
of tRNAGlu (Lu et al., 2005, 2008; Keppetipola et al., 2009, Jain
et al., 2011). Yet, g-toxin has so far eluded a structure determina-
tion. By comparison, knowledge of PaT is sparse. Here, we purify
biologically active homogenous PaT, characterize its anticodon
nuclease activity, determine its atomic structure by X-ray crystal-
lography, and illuminate structure-activity relationships. We also
purify ImmPaT and determine how it interdicts self-killing.
RESULTS
Purification of Bioactive PaT
The bioactivity of PaT can be assayed by galactose-induced
intracellular expression in S. cerevisiae of a version of the PaT
protein that lacks the predicted N-terminal signal peptide and
instead has the N-terminal sequence MNPTTCLNE in which a
new initiating methionine is appended to the native asparagine
(Klassen et al., 2004) (Figure 1C). Here, we found that toxicity
was unaffected when the translation start was shifted oneCell Reports 7, 339–347, April 24, 2014 ª2014 The Authors 339
Figure 1. PaT Is Toxic In Vivo and Incises a Synthetic tRNAGln Stem Loop In Vitro at a Unique Site 30 of the Wobble Uridine
(A) Secreted tRNA ribotoxins defend fungi against nonself species. Pichia acaciae harbors a killer plasmid episome that encodes a secreted heterodimeric toxin.
The chitin-binding Orf1 subunit interacts with the surface of S. cerevisiae target cells and mediates delivery of the toxic PaT (Orf2) subunit into the cytoplasm,
where it arrests the growth of the target cell.
(B) PaT is a tRNA anticodon nuclease that incises tRNAGln(UUG).
(C) Ribotoxicity assay. Schematic depiction of yeast cells harboring the pGAL-PaT plasmid (2m LEU2) in the presence of glucose or galactose as the carbon
source. In this experiment, the N-terminal peptide sequence of PaT was varied as indicated on the left. The reference N-terminal sequence of the unprocessed
PaOrf2 protein is shown at bottom, with the presumed signal peptide in lower case and colored blue. By convention, the asparagine is designated amino acid 2 of
the intracellular PaT (Meineke et al., 2012). Aliquots of serial dilutions of the indicated S. cerevisiae pGAL-PaT strains were spotted on SD-Leu– agar containing
2% glucose or 2% galactose.
(D) Purified recombinant PaT. An aliquot (6 mg) of purified gel-filtered PaT-His6 was analyzed by SDS-PAGE. The Coomassie-blue-stained gel is shown. The
positions and sizes (kDa) of marker polypeptides are indicated on the right.
(E) Anticodon nuclease activity. RNase reaction mixtures (10 ml) containing 10mM Tris-HCl (pH 7.5), 50 mMNaCl, 1 mMDTT, 0.1 mM50 32P-labeled 27-mer stem-
loop RNA (shown at right with the UUG anticodon colored magenta and the 50-labeled nucleotide in red) and either no protein (lane –) or 0.063, 0.125, 0.25, 0.5, 1,
or 2 mM purified PaT-His6 (increasing from left to right) were incubated at 30
C for 60 min. The products were analyzed by urea-PAGE in parallel with size marker
ladders generated by (1) partial alkaline hydrolysis of the same 50 32P-labeled 27-mer RNA substrate (lane OH); (2) partial alkaline hydrolysis of an otherwise
identical 27-mer in which the wobble nucleoside was U20F and thereby alkali-resistant (OH*); and (3) treatment of the
32P-labeled 27-mer RNA with RNase T1,
which cleaves 30 of the lone unpaired guanosine in the anticodon loop to yield a 50-labeled 15-mer with a 30-phosphate end. An autoradiograph of the gel is shown;
the identities of the 30 terminal nucleotides are indicated next to the ladder.
See also Figures S1 and S2.residue to the left, by encoding the N terminus MGNPTTCLNE in
which the glycine derives from the native PaT (Figure 1C). In this
context, the N-terminal methionine will be removed by yeast
methionine aminopeptidase (Moerschell et al., 1990). By phasing
the start site to the right in single amino acid increments, we
determined that replacing Asn2 with methionine did not affect
the toxicity of PaT, as gauged by inhibition of cell growth on
medium containing galactose (Figure 1C). By contrast, deleting
Asn2 and replacing Pro3 with methionine, or deleting Asn2-
Pro3 and replacing Thr4 with methionine, abolished PaT toxicity
and allowed growth on galactose (Figure 1C).
Based on these findings, we elected to purify and characterize
the biologically active version of PaT with the encoded N-termi-
nal sequence MPTTCLNE. The PaT protein was produced in
E. coli with a C-terminal His6 tag and purified by sequential Ni340 Cell Reports 7, 339–347, April 24, 2014 ª2014 The Authorsaffinity, cation exchange, and gel-filtration chromatography
steps. The N-terminal sequence of the apparently homogeneous
recombinant PaT-His6 (Figure 1D) was determined by auto-
mated Edman microchemistry to be PTTCLNEGAI, signifying
that the encoded methionine was removed by E. colimethionine
aminopeptidase.
Anticodon Nuclease Activity: Transesterification
Chemistry and Site Specificity
To gauge anticodon nuclease activity, we incubated PaT with a
50 32P-labeled 27-mer RNA oligonucleotide substrate that com-
prises the anticodon stem loop of yeast tRNAGln(UUG) plus five
extra base pairs at the top of the stem (Figure 1E). Denaturing
PAGE analysis in parallel with a partial alkaline hydrolysate of
the 27-mer showed that PaT incised the anticodon loop at the
Figure 2. Effect of Wobble Base Substitutions and Ribose Modification
(A) Reaction mixtures (10 ml) containing 0.1 mM50 32P-labeled 27-mer stem-loop RNAwith the wobble nucleoside as specified (U, U20F, A, C, or G) and either 2 mM
PaT (lanes +) or no enzyme (lanes –) were incubated at 30C for 60 min. The products were analyzed by urea-PAGE in parallel with partial alkaline hydrolysates of
each of the 32P-labeled 27-mer RNAs (lanes OH). The species in each alkaline ladder corresponding to the 50-fragment cleaved 30 of the wobble nucleoside is
denoted byC.
(B) The extents and sites of incision by PaT of the 27-mer RNAs with U, C, A, or G wobble nucleosides are plotted in bar graph format, where the anticodon loop
sequences are arrayed on the x axes, with the variable wobble nucleobases highlighted in the gray boxes. Each datum in the graphs is the average of three
separate experiments ±SEM. Note that the y axis scales are different in each graph.phosphodiester 30 of the wobble uridine to yield a single 50 32P-
labeled cleavage product that migrated exactly on the alkaline
ladder (Figure 1E), signifying that the PaT cleavage reaction
yielded a 50-OH end on the distal (unlabeled) fragment and either
a 20,30-cyclic phosphate or monophosphate end on the proximal
(labeled) fragment. Definitive assignment of the cleavage site 30
of the wobble uridine was made by (1) comparison to a partial
alkaline hydrolysate of an otherwise identical 27-mer RNA with
a 20-fluorine in lieu of the 20-OH of the wobble uridine sugar, re-
sulting in a skipped hydrolysis site in the alkaline ladder at the
same site incised by PaT; and (2) comparison to a digest of the
27-mer with RNase T1, which cleaved 30 of the unpaired guano-
sine in the anticodon loop (Figure 1E). The extent of incision of
100 nM RNA substrate by PaT was proportional to the protein
concentration from 63 to 500 nM and attained an endpoint of
90% cleavage at 2 mMPaT (Figures 1E and S1A). The apparent
rate constant for anticodon incision under single-turnover condi-
tions (2 mM PaT; 0.1 mM RNA) was 0.12 min1 (Figure S1B).
Definitive assignment of the terminus of the proximal cleavage
fragment as a 20,30-cyclic phosphodiester was made by reacting
PaT with a shorter 50 32P-labeled RNA substrate that would allow
us to discriminate cleavage products with cyclic phosphodiester
versus phosphomonoester ends. For this purpose, we employed
a 17-mer exact mimetic of the tRNAGln(UUG) anticodon stem loop
(Figure S2A) and found that the 50 32P-labeled 8-mer product of
PaT cleavage 30 of the wobble uridine comigrated with the upper
band of a radiolabeled doublet in the alkaline hydrolysis ladder.
The split doublet bands reflect resolution by the PAGE system
of otherwise identical short RNAs according to whether theyhave a 20,30-cyclic phosphate end (the upper species) or a 20-
or 30-monophosphate end (the lower species) (Das and Shuman,
2013).
These results illuminated the chemical mechanism of the PaT
anticodon nuclease, which catalyzes a single transesterification
in which the O20 atom of the wobble nucleoside sugar makes a
nucleophilic attack on the 30-50 phosphodiester to form an RNA
20,3-cyclic phosphodiester and expel a 50-OH RNA leaving
strand (Figure S2B). Consistent with this mechanism, we find
that anticodon cleavage by PaT was abolished by replacing
the ribose 20-OH of the wobble uridine in the 27-mer stem-loop
substrate with a 20-fluorine (Figure 2A). Note that prevention of
RNA transesterification chemistry at the ‘‘normal’’ wobble uri-
dine site did not precipitate cleavage at alternative sites within
the anticodon loop.
The anticodon nuclease activity of PaT did not require a diva-
lent cation cofactor. Inclusion of 10 mM EDTA in the reaction
mixtures was without effect on the extent or site of cleavage
of the 27-mer stem-loop RNA; by contrast, inclusion of 10 mM
MgCl2 inhibited cleavage (not shown). Metal independence
(and inhibition byMg2+) is a property shared with K. lactis g-toxin
(Keppetipola et al., 2009), which, like PaT, cleaves 30 of a wobble
uridine via a transesterification mechanism. g-toxin, which re-
quires the mcm5 wobble uridine modification for its toxicity, is
unable to cleave synthetic oligonucleotide substrates that mimic
the unmodified tRNAGlu(UUC) anticodon stem loop unless the
reactions are supplemented with high concentrations (1–2 M)
of the osmolyte trimethylamine oxide (TMAO) (Lu et al., 2008;
Keppetipola et al., 2009). By contrast, PaT efficiently cleavedCell Reports 7, 339–347, April 24, 2014 ª2014 The Authors 341
an unmodified tRNAGln(UUG) anticodon stem-loop substrate in
the absence of any additive, consistent with the toxicity of PaT
to a yeast elp3D strain that cannot synthesize the mcm5 moiety
(Klassen et al., 2008). Nonetheless, we found that 2 M TMAO
stimulated PaT anticodon nuclease specific activity 4-fold (Fig-
ure S1A) and increased the single-turnover cleavage rate con-
stant 4-fold (Figure S1B), without affecting the site specificity
of cleavage 30 of the wobble uridine (Figure S2A; data not
shown). These experiments unambiguously define the wobble
30 phosphodiester as the target for PaT anticodon incision, and
they cast doubt on earlier interpretations of PaT specificity (Klas-
sen et al., 2008), based on northern blot analysis of the products
of tRNA cleavage by a crude PaT-His6 preparation, imputing
that: (1) PaT cleaves tRNAGln(UUG) at two sites, one 30 of the
wobble uridine and one two nucleotides upstream; (2) PaT
cleaves tRNAGln(UUG) lacking the mcm5U modification only at
the site two nucleotides upstream of the wobble nucleoside;
and (3) mcm5 is required for cleavage at the wobble uridine.
Anticodon Wobble Base Recognition
To probe the role of the wobble nucleobase, we presented PaT
with a set of otherwise identical 27-mer stem-loop substrates
in which the wobble position was either U, C, G, or A and
analyzed the reaction products by urea PAGE (Figure 2A). The
extents of cleavage at nucleotides within the anticodon loop
sequence are plotted in bar graph format for each substrate in
Figure 2B. (Note that the y axis scales are different in each
graph.) The salient findings were as follows: (1) the wobble cyto-
sine reduced cleavage efficiency (to 34%) without affecting
cleavage site choice; (2) the wobble adenine effaced cleavage
at the wobble nucleoside and shifted the incision site by one
nucleotide to the upstream uridine, which was cleaved less
effectively (23%) than the normal wobble U; and (3) the wobble
guanine strongly inhibited cleavage at the wobble position
(2.2%) and elicited only feeble cleavage at the flanking 50 uridine
(2.7%) and 30 uridine (1.4%) positions. We conclude that PaT
‘‘sees’’ the wobble pyrimidine nucleobase in tRNAGln as a key
specificity determinant, with a preference for U over C. These
biochemical properties of pure PaT are consistent with genetic
evidence that the tRNAGln(CUC) isoacceptor is a secondary target
that contributes to PaT toxicity in vivo (Klassen et al., 2008). Note
that none of the wobble base substitutions elicited cleavage at
the uridine two nucleotides upstream of the wobble nucleoside.
Crystal Structure of Pichia acaciae Toxin
Weproduced two versions of recombinant PaT for crystallization
trials: N(Ser),PaT and PaT-His6. The N(Ser),PaT protein was
derived from a His10Smt3,PaT fusion produced at high levels
in bacteria and recovered by Ni-affinity chromatography. Cleav-
age of the His10Smt3 domain by the Smt3-protease Ulp1 yielded
a version of PaT with N-terminal sequence SMNPTTCLNE, in
which the terminal Ser residue originates from the Smt3 fusion
junction. Ulp1 cleavage of His10Smt3,PaT was inefficient
(compared to many other Smt3 fusions we have worked with),
requiring prolonged incubation with high levels of Ulp1, after
which there was a significant fraction of residual intact
His10Smt3,PaT. Although this was not an obstacle to obtaining
large amounts of pure N(Ser),PaT, it suggested that the N ter-342 Cell Reports 7, 339–347, April 24, 2014 ª2014 The Authorsminus of PaT at the Smt3,PaT junction was relatively inacces-
sible. We grew crystals of native N(Ser),PaT by hanging
drop vapor diffusion against a precipitant solution containing
100 mM sodium citrate (pH 5.6), 3.0–3.5 M (NH4)2SO4, 100 mM
magnesium acetate. The native N(Ser),PaT crystal diffracted
X-rays to 1.8 A˚ resolution and belonged to space group
P212121. The structure was solved by using SAD phases
obtained for an isomorphous crystal of SeMet-substituted
N(Ser),PaT that diffracted X-rays to 2.1 A˚ resolution. The
refined model of native N(Ser),PaT at 1.8 A˚ resolution (Rwork/
Rfree = 0.160/0.196; Table S1) consisted of two protomers in
the asymmetric unit. The A protomer model extended from the
N-terminal junction-derived serine to the native C-terminal
Val319, with a two amino acid gap at residues 307–308. The B
protomer model extended from N(Ser) to Lys318. The A and B
protomers of N(Ser),PaT superimposed with an rmsd of 0.75 A˚
at 315 Ca positions. The N(Ser),PaT protomers weremonomeric
in the crystal, consistent with the elution of N(Ser),PaT as a
monomer during preparative gel filtration.
N(Ser),PaT was obtained in 40-fold higher yield than PaT-
His6 when expressed in E. coli, a finding that was puzzling until
we assayed N(Ser),PaT for RNA cleavage and found it to be
inert. We suspect that production of catalytically active PaT-
His6 protein in E. coli was self-limited by PaT’s inhibition of pro-
tein synthesis. To ensure that we captured a structure of an
active form of PaT, we grew crystals of PaT-His6, which were
isomorphous to those of N(Ser),PaT, and then solved the
structure of PaT-His6 at 2.9 A˚ resolution (Rwork/Rfree = 0.188/
0.247) by refinement of the data against the N(Ser),PaT model
(Table S1). The refinedmodel of PaT-His6 extended continuously
from Pro3 (the N terminus of the protein; Figure 1D) to Lys318 in
the A protomer, and from Pro3 to Lys318 with a two amino acid
gap at residues 308–309 in the B protomer.
Except for the extra N-terminal Ser-Met-Asn peptide in N(Ser),
PaT, the tertiary structures of inactive N(Ser),PaT and active
PaT-His6 were virtually identical. The two A protomers aligned
with 0.45 A˚ rmsd at 312 Ca positions and the two B protomers
with0.54 A˚ rmsdat 313Capositions. A superpositionof theApro-
tomer structures (Figure S3) showed that the N terminus of PaT
is located within a recessed pocket (explaining the relative resis-
tance of the His10Smt3,PaT fusion protein to cleavage by Ulp1)
and that the extra N-terminal peptide occluded the ribonuclease
active site (discussed below).
Overview of the PaT Tertiary Structure
PaT is a single-domain protein composed of a helical core
‘‘book-ended’’ between two four-strand b sheets (Figure 3A).
The core comprises fourteen a helices and two 310 helices.
The secondary structure elements are displayed above the
PaT amino acid sequence in Figure 3C. Each of the b sheets is
made up of a pair of b hairpins. The topology of the sheet at
the right of the image in Figure 3A is b2Y,b1[,b8[,b7Y. The
topology of the sheet at left is b4Y,b3[,b5Y,b6[.
A DALI search of the protein database revealed that PaT has a
unique fold; no ‘‘hits’’ were recovered with a Z score >3.5. That
PaT is sui generis in its tertiary structure accords with its lack
of primary structure similarity to any polypeptide except the
Debaryomyces toxin (Figure 3C). The salient point is that the
Figure 3. Crystal Structure of PaT Reveals a Unique Fold
(A) The tertiary structure of PaT-His6 is shown as a ribbon trace with magenta b strands, cyan a helices, blue 310 helices, and beige intervening loops and turns.
The N and C termini of the polypeptide are indicated; selected a helices and b strands are numbered according to their order in the primary structure.
(B) The surfacemodel of PaT in the same orientation as (A), and its vacuum electrostatics were generated in Pymol. Two sulfate anions coordinated on the protein
surface are shown as stick models. A chloride anion is shown as a green sphere.
(C) The aligned primary structures of the Pichia acaciae (Pac) PaT polypeptide and the homologous toxin from Debaryomyces robertsiae (Dro) are shown. Po-
sitions of side-chain identity/similarity are denoted byC above the sequence. Gaps in the alignment are indicated by dashes. The secondary structure elements
of PaT are shown above the amino acid sequence, with b strands rendered as arrows and helices as cylinders, colored as in (A). The amino acids in PaT that were
subjected to alanine scanning in the present study are highlighted in shaded boxes, in green for the essential residues and gray for the nonessential residues.
See also Figure S4.PaT structure is wholly unlike the known structures of any other
transesterifying ribonucleases, e.g., tRNA ribotoxins colicin E5
and colicin D, tRNA splicing endonuclease, mRNA ribotoxin
MazF, rRNA ribotoxin restrictocin, or generic ribonucleases bar-
nase, RNase A and RNase T1 (see comparisons in Figure S4).
A surface electrostatic image of PaT (shown in Figure 3B in the
same orientation as the ribbon tertiary fold image in Figure 3A)
highlights an extended area of positive potential (colored
blue), suggestive of an RNA-binding surface, on which two
lateral sulfate anions and a central chloride anion are docked
(Figure 3B).The PaT Active Site
A stereoview of the PaT-His6 anion-binding pocket, with a sulfate
and chloride engaged, is shown in Figure 4A. The chloride anion
is surrounded by Pro3, Thr4, and Thr5. We speculate that the
chloride overlaps the position of the scissile phosphate, which
would account for the lack of in vivo toxicity of the PaT variants
with alternative translation start sites that replace Pro3 and
Thr4 with Met (Figure 1C). Three basic amino acid side chains
are in the vicinity of the chloride: Arg172, Lys175, and His287.
Arg172 is a central component of a hydrogen-bonding network
that includes Thr5,Glu9, andHis138 (Figure 4A). Lys175 contactsCell Reports 7, 339–347, April 24, 2014 ª2014 The Authors 343
Figure 4. Distinctive Active Site of PaT
(A) Stereoview of the putative active site of PaT-His6 with selected amino acid side chains and main-chain atoms depicted as stick models with beige carbons. A
sulfate anion is rendered as a stick model; a chloride anion is depicted as a green sphere. Atomic contacts are indicated by dashed lines. The side chains found,
by alanine scanning, to be essential for toxicity are denoted by red labels.
(B) Effects of alanine mutations on in vivo toxicity. Aliquots of serial dilutions of the S. cerevisiae pGAL-PaT strains, expressing wild-type PaT or the indicated
alanine mutants, were spotted on SD-Leu– agar containing 2% glucose or 2% galactose. Cells carrying the empty 2m vector were tested in parallel as controls.
Essential residues were those at which alanine substitution permitted growth on galactose.
(C) Effects of selected PaT mutations on anticodon nuclease activity in vitro. Aliquots (5 mg) of the SP-Sepharose preparations of wild-type PaT-His6 and the
R172A, K175A, S283A, and H287A mutants were analyzed by SDS-PAGE. The Coomassie-blue-stained gel is shown in the left panel. The PaT-His6 proteins
(2 mM)were reactedwith the 50 32P-labeled 27-mer stem-loop RNA (0.1 mM) and 2MTMAO for 60min at 30C. The extents of anticodon cleavage are plotted in the
bar graph in the right panel; each datum is the average of three separate experiments ±SEM.
See also Figure S3.the main-chain carbonyls of Tyr83 and Gly86 and makes a
cation-p interaction with the Tyr83 aromatic ring. The nearby sul-
fate anion is coordinated by His138 and the main-chain amide of
Leu124; Lys125 is also proximal to the sulfate (Figure 4A).
To test the relevance of candidate active site functional groups
to PaT bioactivity, we replaced Thr5, Glu9, Lys125, His138,
Arg172, Lys175, and His287 individually with alanine. We also
introduced alanine in lieu of nearby residues Ser283 and
Asp286, and basic residues Lys99 and Lys240 located on the
positively charged surface of PaT, albeit at a distance from the
active site. The PaT-Ala mutants were tested for galactose-
dependent inhibition of S. cerevisiae growth (Figure 4B). The
alanine scan revealed that Thr5, Glu9, His138, Arg172, Lys175,
and His287 were essential for PaT bioactivity, as judged by the344 Cell Reports 7, 339–347, April 24, 2014 ª2014 The Authorsfact that yeast cells expressing the respective alanine mutants
were able to grow on galactose medium (Figure 4B). By contrast,
PaT retained its toxicity when Lys99, Lys125, Lys240, Ser283,
and Asp286 were mutated to alanine, signifying that these side
chains are inessential in vivo.
Selected alanine mutations were introduced into the PaT-His6
context and the PaT-Ala proteins were purified from E. coli (Fig-
ure 4C) and tested for anticodon nuclease activity. The R172A,
K175A, and H287A mutants, which were nontoxic in vivo, were
inactive as anticodon nucleases in vitro (Figure 4C). These inac-
tive PaT-His6 mutants were produced and purified in higher
amounts (4- to 5-fold) than the wild-type PaT-His6, consistent
with PaT nuclease activity exerting a brake on PaT expression.
The bioactive S283A variant retained anticodon nuclease activity
Figure 5. Pichia acaciae Toxin Immunity Protein Binds PaT In Vitro
and Effaces Its Endoribonuclease Activity
(A) Recombinant ImmPaT. An aliquot (6 mg) of purified ImmPaT was analyzed
by SDS-PAGE. The Coomassie-blue-stained gel is shown. The ImmPaT
polypeptide is denoted by=. The positions and sizes (kDa) of marker poly-
peptides are indicated on the left.
(B) ImmPaT inhibits PaT anticodon nuclease activity. PaT-His6 and either
ImmPaT or BSA in amounts specified were preincubated for 5 min at 30C and
then reacted with 0.1 mM (1 pmol) of 50 32P-labeled 27-mer stem-loop RNA for
60 min at 30C. The products were analyzed by urea-PAGE and visualized by
autoradiography.
(C and D) PaT,ImmPaT complex formation. PaT-His6 alone, ImmPaT alone,
and a mixture of PaT-His6 and ImmPaT (1:1.5 molar ratio; preincubated for
5min at 30C)were gel-filtered through a 25ml Superdex 200 column in 10mM
Tris-HCl (pH 7.5), 50 mM NaCl, 1 mM DTT. The superimposed chromato-
graphic profiles (monitored by A280 as a function of elution volume) are shown
as solid lines in (C). The dotted line in (C) depicts the elution profile of a mixture
of ferritin, aldolase, conalbumin, ovalbumin, and carbonic anhydrase, with
native molecular weights (kDa) indicated by arrows, that was used to calibrate
the column. (D) shows the polypeptide composition of the serial column
fractions from the gel-filtration profile of the mixture of PaT-His6 and ImmPaT.
The fractions corresponding to the PaT,ImmPaT complex are indicated by the
bracket.
(E) The PaT,ImmPaT complex has no anticodon nuclease activity. 50
32P-labeled 27-mer stem-loop RNA (20 nM) was reacted with either 0.4 mM
PaT-His6 or PaT,ImmPaT complex (from the peak Superdex fraction denoted
by the magenta dot in D), for 60 min at 30C. The products were analyzed by
urea-PAGE and visualized by autoradiography.in vitro, incising the 27-mer stem-loop substrate 30 of the wobble
uridine with 52% yield (versus 90% for wild-type). These muta-
tional data are consistent with our assignment of the nuclease
active site to the pocket shown in Figure 4A.
The constellation and spatial arrangement of amino acids
in the PaT active site is distinct from other ribonucleases. The
classic mechanism of RNA cleavage by metal-independent
transesterification relies on general base catalysts to abstract a
proton from the ribose O20 nucleophile, general acid catalysts
to donate a proton to the O50 leaving strand, and basic residues
or other hydrogen bond donors to stabilize the pentacoordinate
transition state of the scissile phosphate. The structure and
structure-guided mutational data recommend Glu9, His287,
and/or His138 as potential acid-base catalysts and Arg172 in
transition state stabilization. It is noteworthy that the super-
position of the inactive N(Ser),PaT structure on active PaT-His6
structure highlights perturbations of the active site, particularly
by the nonnative N-terminal Sertag residue, which is tethered
in place via hydrogen bonds to Sertag-Og and the main-chain
carbonyl from the essential Arg172 side chain and from the
Sertag-Og and N-terminal amino nitrogen to Asp286.With the ex-
tra N-peptide docked in this conformation, the Asn2 side chain
occupies the same position as the chloride ion in the PaT-His6
active site. Thus, the extra peptide occludes the active site and
likely accounts for why the N(Ser),PaT is inert as an anticodon
nuclease.
Mechanism of ImmPaT Protection from Self-Killing by
PaT
The P. acaciae cytoplasmic plasmid encodes an immunity factor
ImmPaT that protects the yeast from being killed by uptake
of extracellular toxin. The 363 amino acid ImmPaT protein has
no primary structure similarity to the g-toxin immunity factor
and no resemblance to any protein in the NCBI database
other than the homologous immunity factor from the yeast
Debaryomyces robertsiae. ImmPaT acts intracellularly to
neutralize intracellular PaT by an unknown mechanism (Palus-
zynski et al., 2007). In addition to protecting the toxin-producing
yeast, ImmPaT exerts strong selection pressure to maintain the
killer plasmid during vertical transmission, because daughter
cells of mitotic division that lose the plasmid will be killed by their
toxin-secreting sisters.
In order to query the mechanism of immunity, we produced
ImmPaT in bacteria and purified the recombinant protein (Fig-
ure 5A). The 44 kDa ImmPaT protein gel-filtered as a monomer
(Figure 5C) and had no ribonuclease activity itself when reacted
in 40-fold molar excess with the anticodon stem-loop substrate
(Figure 5B). We found that simply mixing ImmPaT with PaT-His6
at molar ratios of 0.5:1, 1:1, and 2:1 elicited progressive inhibition
of the anticodon nuclease activity of PaT, with complete efface-
ment of the nuclease at a 2:1 ratio of ImmPaT:PaT (Figure 5B).
This was a specific effect of ImmPaT, insofar as a 2-fold excess
of BSA had no effect on PaT (Figure 5B).
To test whether PaT and ImmPaT interact physically, we
mixed the recombinant PaT-His6 and ImmPaT proteins (1:1.5
molar ratio) and subjected the mixture to gel filtration, which re-
vealed the formation of an80 kDa protein complex that was not
present when PaT or ImmPaT alone were gel filtered (Figure 5C).Cell Reports 7, 339–347, April 24, 2014 ª2014 The Authors 345
SDS-PAGE analysis of the eluate fractions showed that the
80 kDa peak comprised a PaT,ImmPaT heterodimer (Fig-
ure 5D). The isolated PaT,ImmPaT complex was devoid of
anticodon nuclease activity (Figure 5E). Thus, the immunity
mechanism of the fungal ribotoxin system entails direct binding
of the immunity factor to the toxin and masking of its nuclease
activity, presumably via steric occlusion of the ribotoxin’s
RNA binding site by the antitoxin, as has been seen with other
ribotoxin,antitoxin pairs (Luna-Cha´vez et al., 2006; Yajima
et al., 2006; Graille et al., 2004; Simanshu et al., 2013).
DISCUSSION
tRNA restriction via incision of the anticodon loop is a deeply
rooted biological response to diverse stresses, including virus
infection, starvation, and reactive oxygen species (Thompson
and Parker, 2009). tRNA restriction also plays a prominent role
in self-nonself distinction, especially among microbial taxa.
Anticodon nucleases elaborated by bacteria and fungi have
extraordinary specificity for their tRNA targets, often dictated
by recognition of a chemicallymodified nucleobase, e.g., wobble
queosine in the case of colicin E5 (Yajima et al., 2006),
wobble mcm5s2U in the case of g-toxin (Lu et al., 2005), and
wobble mnm5s2U plus t6A37 in the case of PrrC (Jiang et al.,
2002). Among tRNA restriction enzymes that recognize the
wobble base, the site of cleavage can either be at the wobble
30-phosphodiester (colicin E5 and g-toxin) or at the wobble
50-phosphodiester (PrrC).
Creating tRNA breaks with a bulky modified base at one of the
broken ends may exploit an Achilles heel in the target cell’s ca-
pacity to repair the tRNA, which in S. cerevisiae can be impeded
by the modified base (Nandakumar et al., 2008; Meineke and
Shuman, 2012). The bacterial tRNA restriction enzyme RloC
(a distant cousin of PrrC) circumvents the potential for tRNA
repair that thwarts PrrC (Amitsur et al., 1987), by incising the anti-
codon loop at two sites, 30 and 50 of the wobble nucleoside, re-
sulting in excision of the intervening wobble mononucleotide
(Davidov and Kaufmann, 2008; Klaiman et al., 2012), so that
repair would result in a nonfunctional tRNA with an internal dele-
tion. It was suggested that PaT also makes two breaks in the
anticodon loop of its targets—30 of the wobble uridine and two
nucleotides upstream—based on the observation of a doublet
cleavage product by northern blotting of the products of a reac-
tion of partially purified PaT with total yeast tRNA (Klassen et al.,
2008; Meineke et al., 2012). However, this interpretation was not
bolstered by direct identification of the positions and chemical
structures of the broken RNA ends (Klassen et al., 2008), nor
was it demonstrated that the predicted dinucleotide excision
product was formed. When the mcm5U wobble modification
was missing, only the lower band of the doublet was observed,
which was interpreted to indicate that PaT makes only one inci-
sion at a site two nucleotides upstream of the unmodifiedwobble
U (Klassen et al., 2008).
In the present study, we show that PaT cleaves a model
tRNAGln(UUG) anticodon stem loop at a single site 30 of the un-
modified wobble uridine, via a metal-independent transesterifi-
cation mechanism that yields 20,30-cyclic phosphate and 50-OH
RNA ends. PaT never cleaves at the uridine two nucleotides up-346 Cell Reports 7, 339–347, April 24, 2014 ª2014 The Authorsstream of the wobble position: not when the wobble cleavage is
suppressed chemically by the wobble 20-F; not when the usual
cleavage is abolished by installing an adenine wobble base
and the cleavage site shifts to the uridine one nucleotide up-
stream. Therefore, we conclude that PaT is an incisional tRNA
restriction enzyme, with inherent specificity for a wobble pyrim-
idine, and limited plasticity with respect to phasing of the scissile
uridine-30-phosphodiester within the anticodon loop.
The crystal structure of PaT presented here reports a cytotoxic
eukaryal tRNA restriction enzyme. In keeping with PaT’s distinc-
tive biochemical specificity and seemingly unique amino acid
sequence devoid of instructive motifs, we found that PaT has a
distinctive tertiary structure and active site. Thus, PaT is the
founder of a new ribonuclease clade, with only one other recog-
nizable fungal member at this point. Structures are available for
a variety of metal-independent transesterifying ribonucleases
with diverse specificities and biological functions (Figure S4).
Although they display distinctive folding topologies in their own
right, these RNases have in common predominantly b structures
and active sites formed by b strands. By contrast, PaT has a pre-
dominantly a structure, including at the active site. It will be inter-
esting to see whether other fungal ribotoxins that are not related
by amino acid sequence to PaT (e.g., g-toxin) have any structural
similarity to PaT, or whether they too are sui generis.
The unveiling of PaT as a structurally unique toxin hints that we
are seeing just the tip of the iceberg of the diversity and evolu-
tionary complexity of the ribotoxin repertoire. In the same vein,
our studies of ImmPaT highlight that the underpinnings of toxin
immunity are just as diverse, albeit organized around a common
principle that immunity reflects a physical inhibition of toxin
nuclease function.
In addition, we can envision practical applications of PaT, a
eukaryal tRNA restriction enzyme, and its antagonist ImmPaT,
as portable agents of tunable eukaryal ribotoxicity. For example,
mammalian cell growth arrest or apoptosis in response to tRNA
restriction might be triggered by (1) simply inducing PaT expres-
sion; or (2) coexpressing PaT and ImmPaT and then shutting off
expression of the immunity protein. tRNA ribotoxicity is regarded
as a potential cancer therapeutic (Ardelt et al., 2009). In bacteria,
tRNA restriction was first discovered as an antiviral mechanism,
one that is evaded by virus-encoded RNA repair system (Amitsur
et al., 1987). The coupling of PaT expression to a eukaryal virus
transcriptional program is a potential means to selectively elim-
inate virus-infected cells.
EXPERIMENTAL PROCEDURES
Assays of PaT Activity
Galactose-inducible PaT toxicity was scored as described in Figure 1C; the
details of plasmid construction andmutagenesis are provided in Supplemental
Experimental Procedures. Anticodon nuclease activity was assayed as spec-
ified in Figure 1E. Detailed methods for radiolabeling and isolating the RNA
substrates and for preparation of RNAmarkers used to map the cleavage sites
are described in Supplemental Experimental Procedures.
Recombinant Proteins, Crystallization, and Structure Determination
PaT-His10, N(Ser),PaT, SeMet-substituted N(Ser),PaT, and ImmPaT-His6
were produced in E. coli and purified from soluble bacterial lysates by Ni-affin-
ity, ion exchange, and gel-filtration chromatography steps as described in
detail in Supplemental Experimental Procedures. Crystals of N(Ser),PaT,
SeMet-substituted N(Ser),PaT, and PaT-His6 were grown at 22
C by hanging
drop vapor diffusion against reservoirs of precipitant solutions containing
100 mM sodium citrate (pH 5.6), 3.0–3.5 M (NH4)2SO4, and either 100 mM
magnesium acetate or 200 mM LiCl. Diffraction data collection and structure
determinations are described in detail in Supplemental Experimental Proce-
dures. The data and refinement statistics and model contents are summarized
in Table S1.
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